Timolol
Timolol is a pharmaceutical drug with 29 clinical trials. Currently 1 active trials ongoing. Historical success rate of 84.0%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
9
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.8%
21 of 26 finished
19.2%
5 ended early
1
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Topical Timolol Benefit in Venous Ulcers
Stop Retinal Ganglion Cell Dysfunction Study
Beta Adrenergic Antagonist for the Healing of Chronic DFU
Clinical Trials (29)
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Topical Timolol Benefit in Venous Ulcers
Stop Retinal Ganglion Cell Dysfunction Study
Beta Adrenergic Antagonist for the Healing of Chronic DFU
Comparison of Latanoprost Vs. Timolol
Circadian Rhythms of Aqueous Humor Dynamics in Humans
Timolol for the Treatment of Acne and Rosacea
Interval Intraocular Pressure in Intravitreal Injection Study
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 29